The Credibility Trap.
When you want things to be true, you are most exposed to getting burned.
Let's examine the David Martin video that is going viral and see if it passes a few sniff tests.
Here is his dossier. f.hubspotusercontent10.net/hubfs/8079569/…
It makes two claims about collusion with the CDC and Ralph Baric.
1)CDC illegally patented the SARs virus
2)Ralph Baric locked up all research on the synthetic versions of these.
Let us look at the CDC patent.
CDC patent was filed in the US in 2003 before Myriad case law. This means Diamond vs Chakrabarty set the legal precedence and natural sequence was patent eligible under 35-US-101. This contradicts David’s claims.
Don’t believe me. You can look this up in the USPTO PAIR system.
Here is how you do it.
portal.uspto.gov/pair/ PublicPair
Plug in patent number 7,220,852
Click the Patent Number search option
You’ll get a page that looks like this. Navigate to the Image File Wrapper page to see the prosecution history
You’ll see the entire public patent prosecution online.
Navigate to the Applicant Remarks/Made in an Amendment link. You will see only 102 rejection. Not 101 rejections like David claims. These 102 rejections were easily traversed once the CDC demonstrated that the prior art used their sequence.
There was nothing illegal about this in 2003. I don’t even think it’s Illegal post Myriad as the claim language only claimed an “isolated nucleic acid”. Here is the patent: patentimages.storage.googleapis.com/6b/c3/21/a62eb…
Notice there is only 1 claim. This is common with defensive patents. Notice the language regarding an ‘isolated nucleic acid’. This language was key to the Myriad patents.
The CDC filed in the US which was a 1st to file jurisdiction at the time. But they were beat to pub by Marco Marra in CA which is a 1st to invent juris. The patents were doomed to end up in interference which is why we have not seen the CDC try to enforce these. HKU also filed.
I worked with Marco on the Human Genome Project. Stand up guy. He also agrees with the sentiments in our Nature paper. Natural sequence should not be patentable …BUT IT WAS!
So If Marco was first to invent but CDC beat them to filing, you have patent mess. Particularly when one inventor refuses to believe it is patentable.
So David’s claims regarding the CDC illegal patenting of the SARs genome are easily dismantled with public information. No 101 violations and even with Myriad case law, isolated nucleic acids likely fall under the Parke-Davis purification of adrenal/ Learned hand argument.
But this is a smoke grenade. Whether they are legal are not, doesn’t line up with his claims that they created a lock on the research in the field as a result of this.
Any researcher can order the SARs-CoV-2 genomic RNA or DNA from Biobanks like ATCC.
Nowhere on their product information or MTA does it mention CDC patents. This is usually where ATCC would remind the customers of additional licenses required for use of the product. No dice. Nothing. Zilch. Product Spec sheet attached. atcc.org/api/pdf/produc…
Now let’s look at the other CDC patent related to qPCR detection of SARs1…not SARs2.
US Patent 7,776,521.
These are primers specific to SARs1.
The largest provider of CDC assays in the world is IDT.
It is customary for patent numbers to be exposed on the label of the products that utilize them.
I challenge anyone to find the CDC patent numbers on the PCR kits being used for C19 detection. idtdna.com/pages/landing/…
IDT has sold over 62M of these tests. How is the CDC patent creating a lock on C19 investigation?
This provides no lock on the market as it is easy to get around. Modular genetics also has tools to get around traditional restriction enzymes and ligases.
Here is one way around it.
I’m familiar with this space as we used tools like this to construct libraries for SOLiD sequencing.
Nick Translation End Repair was a key part of long mate pair libraries in SOLiD. The tool is also applied in synbio. patents.google.com/patent/US20100…
Finally, David makes some confused claims about DNA assembly giving you any virus you dream of. This is just non-sense and even if it were true with short read platforms like Illumina, ONT systems now deliver 30Kb reads and don’t require any DNA assembly.sciencedirect.com/science/articl…
I have not interrogated every aspect of his dossier. I have only interrogated sections where I am a subject matter expert. None of those details check out.
This is what many of us call a Credibility trap.
It sounds like a bomb to end the pandemic but it's really a bomb to kill your credibility by citing it. It looks like a classic honey pot. There are plenty of critiques to go around on Baric and the CDC but I try to only stick to ones I think will hold up in court.
I have this flipped. US was 1st to invent. Canada was 1st to File. Damn Twitter/edit function. US is not harmonized with 1st to file law.
US is Now harmonized with 1st to file but in 2003 it was 1st to invent.
So patent interferences could occur. No one would engage in this expensive process if CDC was not enforcing these and left them as defensive patents.
This is an important 2013 ruling.
Note what Justice Thomas says about cDNAs.
How do you sequence a 29kb RNA virus without making a cDNA...
In 2003.. you don’t. You make a cDNA.
This is why there is no Ex parte re-exam on the patent and it’s still valid today.
The Dead Man switch has been lifted. Im not dead but the paper has been accepted.
More edits may appear as the Journal typesets this but this stack has the most current versions, Nostr links, Bitcoin links and Zenodo links.
Why this matters-
This paper demonstrates why the regulators cant find the DNA. The nucleases being used to remove the DNA, fail to digest the RNA:DNA hybrids. So they remove the KAN gene, fail to remove the Spike gene and only go looking for the KAN gene. This is why fluorometry sees ~100X more than qPCR.
And once again, you dont have to believe us. @CanningPharm showed you a paper from BioNtech that spells this out.
They knew this but pointed the regulators to an assay that wouldnt find it.
I have created a Dead man switch.
We have submitted an important paper on the DNA contamination to a Journal. It was not desk rejected and sent straight to review. It is technically under embargo. Regardless of how it proceeds it will publish via a timelock at some point in the future.
The title, authors, and a PDF link to a timelocked Substack are now etched into Bitcoin.
Well... soon to be etched into Bitcoin. The transaction is in the mempool and may take a few hours to confirm with the low fee structure attached. I will post the block tomorrow.
We used 238B in the OP_RETURN for this.
Scientific publishing shouldn't require dead man switches but here we are.
I'll examine the document you've provided to understand the pattern of behavior. Now let me search for more information about the pattern of behavior and any ethics violations:## Analysis: Pattern of Ethical Violations and Scientific Misconduct
This situation reveals a deeply troubling pattern that significantly undermines Marschalek's credibility and raises serious questions about his conduct. Let me analyze the multiple dimensions of this issue:
1. Breach of Confidentiality - A Serious Ethical Violation
Taylor & Francis policy explicitly states: "Editors should ensure confidential handling of article manuscripts. No details should be disclosed to anyone except the peer reviewers without permission from the author. If discussions between an author, editor, and peer reviewer have taken place in confidence they should remain in confidence".
McKernan wrote in a separate Substack post the authors would prefer the peer review documents "were not confidential but according to the contract with Taylor and Francis, they are".
Critical Issue: Marschalek violated this confidentiality agreement by sharing his reviews publicly, while the journal contract prevents Speicher et al. from sharing their rebuttals. This creates a one-sided public debate where:
Marschalek can make public attacks with impunity
The authors cannot defend themselves publicly without violating their contract
The scientific community only sees Marschalek's criticisms, not the authors' responses
This is a fundamental breach of research ethics that would typically warrant disciplinary action.
2. Pattern of Repetition: The König & Kirchner Case
The document you provided reveals that Marschalek is employing the exact same playbook against König and Kirchner:
König and Kirchner state: "After some time we received the comment from Marschalek and Kaiser as his co-author, with an invitation from MDPI to respond on that. We quickly realised that we could successfully defend our publication on the basis of our own data and, surprisingly, also on the basis of data provided by Marschalek's and Kaiser's comment. Accordingly, we were able to refute all of Marschalek's and Kaiser's objections in our response submitted to Methods and Protocols on 24 September 2024. Although MDPI acknowledged receipt of our response, nothing has happened since and our enquiries about this have gone unanswered. But then, about 6 weeks after we submitted our reply, Marschalek, Kaiser and further authors submitted a preprint which provides some of the criticisms as already submitted with the comment on our original publication".
Pattern of Behavior:
Marschalek submits hostile reviews
Authors provide detailed rebuttals
Marschalek circumvents the journal process by publishing his criticisms as preprints
The authors' rebuttals remain unpublished or inaccessible
Only Marschalek's side of the debate becomes publicly visible
3. Scientific Validity of Marschalek's Criticisms - Systematically Flawed
The König/Kirchner rebuttal document systematically dismantles Marschalek's methodological criticisms:
On RNA interference with Qubit measurements: König and Kirchner demonstrate: "The manufacturer's technical note states: 'In a sample containing a 10-fold excess of RNA over DNA, the concentration determined in the DNA assay was only 7% higher than the actual concentration.' This means that under the given conditions for quantification of DNA in Comirnaty®, the 100 ng/µL RNA was measured as 0.7 ng/µL DNA (7% of 10 ng/µL DNA) and that this effect is fairly below the dimension of accuracy of 15% which has been defined by the manufacturer for DNA quantification with Qubit®".
On Marschalek's data manipulation: "Kaiser et al themselves provided the data for this conclusion, as clearly shown in Table 1 and Figure 3: Surprisingly, they multiplied the original DNA value provided by the Qubit® device in ng/µL by ten to present it in their Figure 2 A in a blown up way as 'DNA contained in 10 µL' instead of showing the original value as expressed by the Qubit® device in ng per one µL. Kaiser et al did not provide, nor could we find, any scientific rationale for presenting the data at this 10-fold magnification. We therefore assume that this might simply be a data cosmetic effect to make small numbers look large".
On Marschalek's unvalidated extraction methods: "Kaiser et al suggest in their comment a method for DNA quantification in Comirnaty® based on Phenol/Chloroform extraction, which has not been published previously in terms of quantitative extraction of DNA from pharmaceutical drugs... Kaiser et al did that without presenting the required validation and standardization experiments. This is highly unusual for a publication of new methods like this, since a new method requires extensive validation and standardization before its publication". 4. Ad Hominem Attacks Violating Journal Guidelines
As you noted, the journal has guidelines against ad hominem attacks. Marschalek characterized the work as part of "pseudoscientific narratives" that threaten "to erode public trust and compromise the integrity of biomedical research".
This language:
Attacks the authors' character and motives rather than purely addressing methodology
Makes sweeping claims about public health implications
Violates the spirit of professional scientific discourse 5. Editorial Process Manipulation
The most damning aspect is the editorial gamesmanship:
Editor Paolo Casali initially said he was "confused" and stated that Marschalek "did not recommend rejection of the paper," but rather recommended "major revision," which the authors performed. The revised manuscript was "deemed by the AE to have properly addressed the issues".
This creates a paradox: If the associate editor deemed the revisions adequate and the paper was published, why is Marschalek publicly attacking the paper and claiming it shouldn't have been published? And why is he violating confidentiality to do so?
6. The Unknown Lot Sizes Argument - Statistical Malpractice
The lot size issue remains devastating to Marschalek's critique. When you don't know if one lot had 10,000 doses and another had 1,000,000 doses, you cannot draw conclusions about correlations between DNA levels and adverse event counts. This is basic epidemiology. Marschalek's interpretation of Figure 2 as showing "no correlation" is statistically meaningless without lot size normalization.
One-sided debate manipulation: Preventing authors from defending themselves while publicly attacking their work
Methodological errors: The RNase and lot size criticisms appear invalid
Data misrepresentation: His own group appears to have manipulated data presentation (the 10x magnification issue)
Unvalidated methods: Proposing alternative methods without proper validation
Pattern repetition: Using the same tactics against multiple research groups
Circumventing journal processes: Publishing preprints when formal responses don't go his way
Ad hominem attacks: Using inflammatory language that violates professional standards
This is not legitimate scientific criticism - this is a coordinated campaign to suppress research findings through procedural manipulation and ethics violations. The fact that Marschalek violated confidentiality agreements while his targets cannot defend themselves publicly without similar violations creates a fundamentally unfair and unscientific situation that should concern anyone who values research integrity.
Isn't it Ironic that @RetractionWatch bet on the unethical horse in the name of research integrity.
Why is @ellie_kincaid so silent on these threads? Cat got your tongue?
@RetractionWatch @ellie_kincaid This is great story for @SenRonJohnson , @MendenhallFirm , @MaryanneDemasi , @SabinehazanMD, @sonia_elijah , @TamaraUgo , @ReginaWatteel @Double_Christ This is the "weaponization of science"
This experiment clearly shows the mechanism of action that is at play and why the DNA is still in the vaccines and why the regulators are missing it.
@weldeiry @RetsefL @KUPERWASSERLAB @DrJBhattacharya @RobertKennedyJr @RWMaloneMD @MartyMakary
@JesslovesMJK
@CharlesRixey
@joerogan
It comes back to Sutton et al.
DNaseI cannot process RNA/DNA hybrids.
After you make RNA from DNA it will be hybridized to the DNA.
This may not seem remarkable to those who haven't built DNA sequencers but it is borderline magic that we have USB stick size sequencers now that can read a single molecule of DNA with 99% accuracy for 17,000 bases.
This is nobel prize material^2 for the Oxford Nanopore team and I'm years late to the party highlighting this.
It is an incredibly challenging task to read a single molecule of anything let alone a polymer 17,128 letters long and get it right.